Research
Hormonal
Low levels of Dehydroepiandrosterone sulfate (DHEAS) are associated with a higher cross-sectional burden of multimorbidity in older adults.
Low levels of the hormone DHEAS are linked to having more chronic diseases in older adults. While not as strong a predictor of future disease progression as IL-6, low DHEAS is a marker of hormonal dysregulation associated with a higher burden of illness.
GoodSupportsHIGH confidence
lower dehydroepiandrosterone sulfate were associated with higher number of diseases, independent of age, sex, body mass index, and education.
Why this rating
Longitudinal study with robust statistical adjustment for covariates.
Source
Aging and the Burden of Multimorbidity: Associations With Inflammatory and Anabolic Hormonal Biomarkers
Elisa Fabbri et al. · The Journals of Gerontology Series A · 2014
DOI 10.1093/gerona/glu127
cohort · n=1018Cited 236×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →